|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2004-9-15
|
|
pubmed:abstractText |
To compare expected outcomes and costs of care in patients with chronic schizophrenia or schizoaffective disorders who are treated with risperidone versus olanzapine.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1098-3015
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
7
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
569-84
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:15367252-Antipsychotic Agents,
pubmed-meshheading:15367252-Benzodiazepines,
pubmed-meshheading:15367252-Body Mass Index,
pubmed-meshheading:15367252-Chronic Disease,
pubmed-meshheading:15367252-Female,
pubmed-meshheading:15367252-Humans,
pubmed-meshheading:15367252-Male,
pubmed-meshheading:15367252-Markov Chains,
pubmed-meshheading:15367252-Outcome Assessment (Health Care),
pubmed-meshheading:15367252-Psychotic Disorders,
pubmed-meshheading:15367252-Recurrence,
pubmed-meshheading:15367252-Risperidone,
pubmed-meshheading:15367252-Schizophrenia
|
|
pubmed:articleTitle |
Outcomes and costs of risperidone versus olanzapine in patients with chronic schizophrenia or schizoaffective disorders: a Markov model.
|
|
pubmed:affiliation |
Policy Analysis Inc. (PAI), Brookline, MA 02445, USA.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
